Cargando…

Is the extirpative surgery for primary tumor helpful for the patients with metastatic urothelial cancer at the time of diagnosis?

The stagnant mortality rates for metastatic urothelial cancer (UC) have provoked efforts to find novel treatments. To test the utility of the extirpative surgery for primary tumor as an option for these patients, we investigated the perioperative and oncologic outcomes of surgery for primary tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jongchan, Park, Sung Yul, Elghiaty, Ahmed, Jang, Won Sik, Heo, Ji Eun, Park, Jee Soo, Choi, Young Deuk, Ham, Won Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708713/ https://www.ncbi.nlm.nih.gov/pubmed/31145361 http://dx.doi.org/10.1097/MD.0000000000015930

Ejemplares similares

Management of postoperative ileus after robot-assisted laparoscopic prostatectomy
por: Park, Jee Soo, et al.
Publicado: (2018)

Predictive value of preoperative monocyte–lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging
por: Elghiaty, Ahmed, et al.
Publicado: (2018)

Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion
por: Kim, Jongchan, et al.
Publicado: (2019)

Recent global trends in testicular cancer incidence and mortality
por: Park, Jee Soo, et al.
Publicado: (2018)

Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies
por: Ham, Won Sik, et al.
Publicado: (2022)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Ham, Won Sik, et al.
Publicado: (2021)

Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
por: Heo, Ji Eun, et al.
Publicado: (2019)

Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
por: Park, Jee Soo, et al.
Publicado: (2022)

Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2019)

Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2022)

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
por: Kim, Jongchan, et al.
Publicado: (2017)

Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model
por: Park, Jee Soo, et al.
Publicado: (2021)

Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer
por: Lee, Jongsoo, et al.
Publicado: (2020)

Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
por: Park, Jee Soo, et al.
Publicado: (2021)

Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis
por: Park, Jae Won, et al.
Publicado: (2018)

Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients with Localized Pathologic T1N0M0 Stage Disease
por: Park, Jee Soo, et al.
Publicado: (2020)

Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
por: Park, Cheol Keun, et al.
Publicado: (2021)

Intravesical Recurrence after Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma Is Associated with Flexible Diagnostic Ureteroscopy, but Not with Rigid Diagnostic Ureteroscopy
por: Ha, Jee Soo, et al.
Publicado: (2022)

Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents
por: Han, Jang Hee, et al.
Publicado: (2017)

Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
por: Cho, Yeona, et al.
Publicado: (2016)

Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
por: Park, Jee Soo, et al.
Publicado: (2020)

Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
por: Park, Jae Won, et al.
Publicado: (2018)

Efficacy and Safety of Robotic Procedures Performed Using the da Vinci Robotic Surgical System at a Single Institute in Korea: Experience with 10000 Cases
por: Koh, Dong Hoon, et al.
Publicado: (2018)

The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity
por: Park, Jee Soo, et al.
Publicado: (2021)

Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery
por: Heo, Ji Eun, et al.
Publicado: (2020)

Renal Pelvic Urothelial Carcinoma With Vena Caval Thrombus Mimicking Renal Cell Carcinoma
por: Diaz, Richilda Red, et al.
Publicado: (2014)

Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
por: Park, Cheol Keun, et al.
Publicado: (2021)

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2020)

Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
por: Han, Hyunho, et al.
Publicado: (2022)

Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy
por: Jeon, Jinhyung, et al.
Publicado: (2023)

The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer
por: Jang, Won Sik, et al.
Publicado: (2016)

A rare presentation of metastatic prostate cancer, initially a suspect for urothelial cell carcinoma of the ureter: a case report
por: Chung, Ho Seok, et al.
Publicado: (2017)

Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy
por: Jang, Won Sik, et al.
Publicado: (2016)

Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
por: Han, Hyunho, et al.
Publicado: (2021)

EXTIRPATION OF THE THYMUS IN THE GUINEA PIG
por: Park, Edwards A.
Publicado: (1917)

Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
por: Park, Jae Won, et al.
Publicado: (2018)

Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma
por: Choi, Hoon, et al.
Publicado: (2020)

Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up
por: Lee, Jongsoo, et al.
Publicado: (2022)

Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging
por: Lee, Suk-Hyun, et al.
Publicado: (2021)

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
por: Kang, Yong Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j3toha26smocf76rccbov40kki